Trading mostly below its five-year forward averages; together with an attractive yield; IFM's latest share grab has been labeled opportunistic. That sounds like a BUY here.
What is covered in the Full Insight:
Atlas Arteria's Rejected Proposal
IFM's Involvement and share Growth
Board Representation and Share Value
Potential Future Moves
Insight into Recent Performance
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.